Morales-Pacheco M, Valenzuela-Mayen M, Gonzalez-Alatriste A, Mendoza-Almanza G, Cortes-Ramirez S, Losada-Garcia A
Biomark Res. 2025; 13(1):27.
PMID: 39934930
PMC: 11818056.
DOI: 10.1186/s40364-025-00742-w.
Zhang Q, Wang Y, Shi W, Chen Y, He Z, Yu L
Sci Rep. 2025; 15(1):1819.
PMID: 39805912
PMC: 11731002.
DOI: 10.1038/s41598-024-84343-x.
Yu Z, Chi W, Wang C, Qiu Y, Qiu Z, Zhu W
Am J Transl Res. 2024; 16(11):6991-7015.
PMID: 39678538
PMC: 11645627.
DOI: 10.62347/VZAW2270.
Li Q, Zhang C, Ren Y, Qiao L, Xu S, Li K
Front Immunol. 2024; 15:1477427.
PMID: 39606245
PMC: 11599260.
DOI: 10.3389/fimmu.2024.1477427.
Isingizwe Z, Sjoelund V, Benbrook D
Cancers (Basel). 2024; 16(20).
PMID: 39456628
PMC: 11506604.
DOI: 10.3390/cancers16203533.
Platelet and epithelial cell interations can be modeled in cell culture, and are not affected by dihomo-gamma-linolenic acid.
Isingizwe Z, Mortan L, Benbrook D
PLoS One. 2024; 19(8):e0309125.
PMID: 39190751
PMC: 11349180.
DOI: 10.1371/journal.pone.0309125.
Microphysiological systems as models for immunologically 'cold' tumors.
Gaebler D, Hachey S, Hughes C
Front Cell Dev Biol. 2024; 12:1389012.
PMID: 38711620
PMC: 11070549.
DOI: 10.3389/fcell.2024.1389012.
The localization, origin, and impact of platelets in the tumor microenvironment are tumor type-dependent.
Le Chapelain O, Jadoui S, Gros A, Barbaria S, Benmeziane K, Ollivier V
J Exp Clin Cancer Res. 2024; 43(1):84.
PMID: 38493157
PMC: 10944607.
DOI: 10.1186/s13046-024-03001-2.
Perioperative Platelet Count Ratio Predicts Long-Term Survival after Left Pancreatectomy and Splenectomy for Pancreatic Adenocarcinoma.
Nachmany I, Gudmundsdottir H, Meiri H, Eidelman P, Ziv O, Bear L
J Clin Med. 2024; 13(4).
PMID: 38398363
PMC: 10888544.
DOI: 10.3390/jcm13041050.
Extracellular Vesicles, Circulating Tumor Cells, and Immune Checkpoint Inhibitors: Hints and Promises.
Bandini S, Ulivi P, Rossi T
Cells. 2024; 13(4.
PMID: 38391950
PMC: 10887032.
DOI: 10.3390/cells13040337.
Macrophages and platelets in liver fibrosis and hepatocellular carcinoma.
Casari M, Siegl D, Deppermann C, Schuppan D
Front Immunol. 2023; 14:1277808.
PMID: 38116017
PMC: 10728659.
DOI: 10.3389/fimmu.2023.1277808.
The dynamic role of platelets in cancer progression and their therapeutic implications.
Li S, Lu Z, Wu S, Chu T, Li B, Qi F
Nat Rev Cancer. 2023; 24(1):72-87.
PMID: 38040850
DOI: 10.1038/s41568-023-00639-6.
Evaluation of cell surface vimentin positive circulating tumor cells as a prognostic biomarker for stage III/IV colorectal cancer.
Yu J, Yang M, Peng T, Liu Y, Cao Y
Sci Rep. 2023; 13(1):18791.
PMID: 37914786
PMC: 10620146.
DOI: 10.1038/s41598-023-45951-1.
Platelet Contributions to the (Pre)metastatic Tumor Microenvironment.
Roweth H
Semin Thromb Hemost. 2023; 50(3):455-461.
PMID: 37832586
PMC: 11177183.
DOI: 10.1055/s-0043-1776005.
cross-talk between metastasis-competent circulating tumor cells and platelets in colon cancer: a malicious association during the harsh journey in the blood.
Eslami-S Z, Cortes-Hernandez L, Glogovitis I, Antunes-Ferreira M, DAmbrosi S, Kurma K
Front Cell Dev Biol. 2023; 11:1209846.
PMID: 37601099
PMC: 10433913.
DOI: 10.3389/fcell.2023.1209846.
Upregulation of girdin delays endothelial cell apoptosis via promoting engulfment of platelets.
Lan Y, Dong M, Li Y, Diao Y, Chen Z, Wu Z
Mol Biol Rep. 2023; 50(10):8111-8120.
PMID: 37548867
DOI: 10.1007/s11033-023-08625-9.
Platelet RNA signature independently predicts ovarian cancer prognosis by deep learning neural network model.
Liu C, Li H, Gao Y, Xie G, Chi J, Li G
Protein Cell. 2023; 14(8):618-622.
PMID: 37526343
PMC: 10392027.
DOI: 10.1093/procel/pwac053.
Systemic inflammation factors as survival prognosis markers in ovarian neoplasm and the relationship with cancer-associated inflammatory mediators-a review.
Dinca A, Diaconu A, Birla R, Coculescu B, Dinca V, Manole G
Int J Immunopathol Pharmacol. 2023; 37:3946320231178769.
PMID: 37246293
PMC: 10226927.
DOI: 10.1177/03946320231178769.
Platelet RNA enables accurate detection of ovarian cancer: an intercontinental, biomarker identification study.
Gao Y, Liu C, Li H, Xiong X, Li G, In t Veld S
Protein Cell. 2023; 14(6):579-590.
PMID: 36905391
PMC: 10246718.
DOI: 10.1093/procel/pwac056.
Interactions between Platelets and Tumor Microenvironment Components in Ovarian Cancer and Their Implications for Treatment and Clinical Outcomes.
Oncul S, Cho M
Cancers (Basel). 2023; 15(4).
PMID: 36831623
PMC: 9953912.
DOI: 10.3390/cancers15041282.